Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 53, doi. 10.1046/j.1468-1293.2003.00119.x
- By:
- Publication type:
- Article
Works matching IS 14642662 AND DT 2003 AND VI 4 AND IP 1
Results: 11
1
2
Patterns of antiretroviral use in the United States of America: analysis of three observational databases.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 24, doi. 10.1046/j.1468-1293.2003.00129.x
- By:
- Publication type:
- Article
3
Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 33, doi. 10.1046/j.1468-1293.2003.00130.x
- By:
- Publication type:
- Article
4
Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 72, doi. 10.1046/j.1468-1293.2003.00131.x
- By:
- Publication type:
- Article
5
Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients*.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 18, doi. 10.1046/j.1468-1293.2003.00132.x
- By:
- Publication type:
- Article
6
Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 38, doi. 10.1046/j.1468-1293.2003.00133.x
- By:
- Publication type:
- Article
7
P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitors.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 67, doi. 10.1046/j.1468-1293.2003.00134.x
- By:
- Publication type:
- Article
8
The use of calcium carbonate in nelfinavir-associated diarrhoea in HIV-1-infected patients.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 48, doi. 10.1046/j.1468-1293.2003.00135.x
- By:
- Publication type:
- Article
9
Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 62, doi. 10.1046/j.1468-1293.2003.00136.x
- By:
- Publication type:
- Article
10
Findings from the first national clinical audit of treatment for people with HIV.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 11, doi. 10.1046/j.1468-1293.2003.00137.x
- By:
- Publication type:
- Article
11
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 1, doi. 10.1046/j.1468-1293.2003.00138.x
- By:
- Publication type:
- Article